Genetic influence of IFN-γ gene polymorphisms on hepatitis C progression and recovery

Khair Rafiq1, Sanaullah Khan1, Muhammad Bar Khan1

  • 1Institute of Zoological Sciences, University of Peshawar, Khyber Pakhtunkhwa, Pakistan.

PubMed

Insights

Certain gene variations in interferon gamma (IFN-γ) and interferon gamma receptor-1 (IFN-γR1) are linked to Hepatitis C virus (HCV) infection outcomes. Specific genotypes may increase susceptibility or aid in viral clearance.

Area of Science:

  • Immunogenetics
  • Hepatology
  • Virology

Background:

  • Hepatitis C virus (HCV) infection poses significant health risks, often leading to severe liver complications.
  • Interferon gamma (IFN-γ) and its receptor-1 (IFN-γR1) genes are crucial in managing viral infections.
  • Genetic variations in these genes may influence the course and outcome of HCV infections.

Purpose of the Study:

  • To investigate the association between polymorphisms in the IFN-γ and IFN-γR1 genes and outcomes of HCV infection.
  • To analyze the genetic influences of specific gene variants on susceptibility and clearance of HCV.

Main Methods:

  • A cross-sectional study involving 320 participants (160 HCV patients and 160 healthy controls).
  • HCV patients were categorized into spontaneous viral clearance (SVC), chronic hepatitis C (CHC), and sustained virological response (SVR) groups.
  • Genotyping of IFN-γ intron-1 and IFN-γR1 promoter regions was performed using PCR and Sanger sequencing.

Main Results:

  • IFN-γ genotype AT was significantly more prevalent in CHC patients (57.0%), while TT genotype was higher in SVC (54.0%).
  • IFN-γR1 genotype TC was frequent in CHC patients (42.60%), whereas CC genotype was more common in SVC (48.0%).
  • Significant associations were found between specific genotypes and HCV infection outcomes (p<0.0001).

Conclusions:

  • The IFN-γ AT and IFN-γR1 TC genotypes are associated with increased susceptibility to Hepatitis C.
  • The IFN-γ TT and IFN-γR1 CC genotypes may play a role in influencing viral recovery or clearance in HCV infection.
Abstract